Patent ductus arteriosus closure

Journal of Interventional Cardiology

Volumn 19, Issue SUPPL. 5, 2006, Pages

  Krasuski, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

AORTOGRAPHY; ARTERY CATHETERIZATION; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; BLEEDING; BLOOD VESSEL INJURY; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART VOLUME; HUMAN; NERVE INJURY; PATENT DUCTUS ARTERIOSUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SECOND LOOK SURGERY; SURGICAL INFECTION; SURGICAL TECHNIQUE; WOUND CLOSURE;

EID: 33749022490     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00172.x     Document Type: Review

References (34)

1. Perloff JG. Patent ductus arteriosus. In: Clinical Recognition of Congenital Heart Disease. 5th ed. Philadelphia: Saunders, 2003, pp. 403-429.
2. Gittenberger-de Groot AC, Strengers JL, Mentink M, et al. Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol 1985;6:394-404.
3. Gittenberger-de Groot AC, Strengers JL. Histopathology of the arterial duct (ductus arteriosus) with and without treatment with prostaglandin E1. Int J Cardiol 1988;19:153-166.
4. Barst RJ, Gersony WM. The pharmacological treatment of patent ductus arteriosus. A review of the evidence. Drugs 1989;38:249-266.
5. Brili SV, Toutouzas P. Patent arterial duct and aortopulmonary window. In: Gatzoulis MA, Webb GD, Daubeney PEF, eds. Diagnosis and Management of Adult Congenital Heart Disease. New York: Churchill Livingstone, 2003, pp. 247-252.
6. Lankipalli RS, Lax K, Keane MG, et al. Images in cardiovascular medicine. Infected patent ductus arteriosus. Circulation 2005;112:e364-e365.
7. Therrien J, Connelly MS, Webb GD. Patent ductus arteriosus. Curr Treat Options Cardiovasc Med 1999;1:341-346.
8. Roberts KE, McElroy JJ, Wong WP, et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004;24:371-374.
9. Berman EB, Barst RJ. Eisenmenger's syndrome: Current management. Prog Cardiovasc Dis 2002;45:129-138.
10. Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989;63:877-880.
11. Tsukamoto S, Shindo S, Obana M, et al. Closure of calcified patent ductus arteriosus. Ann Thorac Cardiovasc Surg 2000;6:54-56.
12. Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon 1967;12:259-261.
13. Moore JW, Levi DS, Moore SD, et al. Interventional treatment of patent ductus arteriosus in 2004. Catheter Cardiovasc Interven 2005;64:91-101.
14. Rashkind WJ, Mullins CE, Hellenbrand WE, et al. Nonsurgical closure of patent ductus arteriosus: Clinical application of the Rashkind PDA Occluder System. Circulation 1987;75:583-592.
15. Lloyd TR, Fedderly R, Mendelsohn AM, et al. Transcatheter occlusion of patent ductus arteriosus with Gianturco coils. Circulation 1993;88(4 Pt 1):1412-1420.
16. Moore JW, George L, Kirkpatrick SE. Closure of residual patent ductus arteriosus with occluding spring coil after implant of a Rashkind occluder. Am Heart J 1994;127(4 Pt 1):943-945.
17. Grifka RG. Transcatheter closure of the patent ductus arteriosus. Catheter Cardiovasc Interven 2004;61:554-570.
18. Moore JW, Schneider DJ, Dimeglio D. The duct-occlud device: Design, clinical results, and future directions. J Interven Cardiol 2001;14:231-237.
19. Masura J, Gavora P, Podnar T. Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: Initial clinical experience. Catheter Cardiovasc Interven 2003;58:261-267.
20. Rao PS, Kim SH, Choi JY, et al. Follow-up results of transvenous occlusion of patent ductus arteriosus with the buttoned device. J Am Coll Cardiol 1999;33:820-826.
21. Roy A, Juneja R, Saxena A. Use of Amplatzer duct occluder to close severely hypertensive ducts: Utility of transient balloon occlusion. Indian Heart J 2005;57:332-336.
22. Krasuski RA, Warner JJ, Wang A, et al. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 2000;36:2204-2211.
23. Alwi M, Kang LM, Samion H, et al. Transcatheter occlusion of native persistent ductus arteriosus using conventional Gianturco coils. Am J Cardiol 1997;79:1430-1432.
24. Patel HT, Cao QL, Rhodes J, et al. Long-term outcome of transcatheter coil closure of small to large patent ductus arteriosus. Catheter Cardiovasc Interven 1999;47:457-461.
25. Fedderly RT, Beekman RH, 3rd, Mosca RS, et al. Comparison of hospital charges for closure of patent ductus arteriosus by surgery and by transcatheter coil occlusion. Am J Cardiol 1996;77:776-779.
26. Singh TP, Morrow WR, Walters HL, et al. Coil occlusion versus conventional surgical closure of patent ductus arteriosus. Am J Cardiol 1997;79:1283-1285.
27. Galal MO, Bulbul Z, Kakadekar A, et al. Comparison between the safety profile and clinical results of the Cook detachable and Gianturco coils for transcatheter closure of patent ductus arteriosus in 272 patients. J Interven Cardiol 2001;14:169-177.
28. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: Immediate results of the international clinical trial. Catheter Cardiovasc Interven 2000;51:50-54.
29. Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: Initial and one-year results. J Am Coll Cardiol 2004;44:513-519.
30. Joseph G, Mandalay A, Zacharias TU, et al. Severe intravascular hemolysis after transcatheter closure of a large patent ductus arteriosus using the Amplatzer duct occluder: Successful resolution by intradevice coil deployment. Catheter Cardiovasc Interven 2002;55:245-249.
31. Tomita H, Fuse S, Akagi T, et al. Hemolysis complicating coil occlusion of patent ductus arteriosus. Cathet Cardiovasc Diagn 1998;43:50-53.
32. Galal MO. Advantages and disadvantages of coils for transcatheter closure of patent ductus arteriosus. J Interven Cardiol 2003;16:157-163.
33. Frost AE, Quinones MA, Zoghbi WA, et al. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 2005;24:501-503.
34. Arora R, Singh S, Dalra GS. Patent ductus arteriosus: Catheter closure in the adult patient. J Interven Cardiol 2001;14:255-259.